Jeremy
Ferric Ammonium Citrate Upregulates PD-L1 Expression through Generation of Reactive Oxygen Species
Ferric ammoniumcitrate (FAC)-induced inhibition of osteoblast proliferation/differentiation and its reversal by soybean-derived peptides (SDP)
Ammonium Ferric Citrate induced Ferroptosis in Non-Small-Cell Lung Carcinoma through the inhibition of GPX4-GSS/GSR-GGT axis activity
Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells
Structures of disodium hydrogen citrate mono-hydrate, Na 2 HC 6 H 5 O 7(H 2 O), and di-ammonium sodium citrate, (NH 4) 2 NaC 6 H 5 O 7, from powder diffraction data
Ferric ammonium citratefrom MedKoo Biosciences |
592821 |
10.0g: 260.00 EUR |
Ferric Ammonium Citratefrom Glycomatrix |
40600001-1 |
100 g: 34.83 EUR |
Ferric Ammonium Citratefrom Glycomatrix |
40600001-2 |
500 g: 99.26 EUR |
Ferric Ammonium Citratefrom Glycomatrix |
40600001-3 |
1 kg: 159.04 EUR |
FERRIC AMMONIUM CITRATEfrom PhytoTechnology Laboratories |
F374 |
100G: 62.21 EUR |
Ferric ammonium citratefrom EWC Diagnostics |
PCT0107-100G |
1 unit: 6.93 EUR |
Ferric ammonium citratefrom EWC Diagnostics |
PCT0107-500G |
1 unit: 10.18 EUR |
Bismuth Ammonium Citratefrom Glycomatrix |
40200095-1 |
100 g: 63.86 EUR |
Bismuth Ammonium Citratefrom Glycomatrix |
40200095-2 |
500 g: 207.46 EUR |
Ammonium citrate dibasicfrom Pfaltz & Bauer |
A29994 |
100G: 151.30 EUR |
Ammonium citrate, dibasicfrom Bio Basic |
AB0059 |
500g: 78.79 EUR |
Ammonium Citrate Tribasicfrom Glycomatrix |
40100312-1 |
100 g: 19.64 EUR |
Ammonium Citrate Tribasicfrom Glycomatrix |
40100312-2 |
500 g: 59.66 EUR |
Ammonium citrate, tribasicfrom Bio Basic |
AB0060 |
250g: 72.53 EUR |
Fluorimetry of selenium in body fluids after digestion with nitric acid, magnesium nitrate hexahydrate, and hydrochloric acid.
Ab Initio Molecular Dynamics Study of Aqueous Solutions of Magnesium and Calcium Nitrates: Hydration Shell Structure, Dynamics and Vibrational Echo Spectroscopy
Subsequently, we looked at the dynamics of frequency fluctuations of OD modes of heavy water in different hydration environments. Specifically, the temporal decay of spectral observables of two-dimensional infrared (2DIR) spectroscopy, three pulse echo peak shift (3PEPS) measurements and also of time correlations of frequency fluctuations are calculated to investigate the dynamics of vibrational spectral diffusion of water in different hydration environments in these solutions.
Effect of molten sodium nitrate on the decomposition pathways of hydrated magnesium hydroxycarbonate to magnesium oxide probed by in situ total scattering
Magnesium reduces cadmium accumulation by decreasing the nitrate reductase-mediated nitric oxide production in Panax notoginseng roots.
Electrochemical nitrate removal with simultaneous magnesium recovery from a mimicked RO brine assisted by in situ chloride ions.
MAGNESIUM NITRATEfrom PhytoTechnology Laboratories |
M542 |
1KG: 247.58 EUR |
Magnesium Nitrate Hexahydratefrom NACALAI TESQUE |
20918-35 |
500G: 16.80 EUR |
Magnesium Nitrate Hexahydratefrom NACALAI TESQUE |
20919-12 |
25G: 8.75 EUR |
Magnesium Nitrate Hexahydratefrom NACALAI TESQUE |
20919-25 |
500G: 19.25 EUR |
Magnesium Nitrate Hexahydratefrom Glycomatrix |
41300003-1 |
500 g: 38.88 EUR |
Magnesium Nitrate Hexahydratefrom Glycomatrix |
41300003-2 |
1 kg: 62.87 EUR |
Magnesium Nitrate Hexahydratefrom Glycomatrix |
41300003-3 |
5 kg: 224.51 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-1 |
1: 35.50 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-1KG |
1 kg: 79.20 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-250 |
250: 15.70 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-250G |
250 g: 52.80 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-5 |
5: 146.30 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-500 |
500: 23.80 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-500G |
500 g: 64.80 EUR |
Magnesium nitrate hexahydratefrom Glentham Life Sciences |
GK0164-5KG |
5 kg: 213.60 EUR |
Magnesium nitrate hexahydratefrom Bio Basic |
MB0586 |
500g: 80.88 EUR |
Magnesium nitrate hexahydratefrom EWC Diagnostics |
PCT0007-1KG |
1 unit: 17.80 EUR |
Magnesium nitrate hexahydratefrom EWC Diagnostics |
PCT0007-500G |
1 unit: 9.89 EUR |
Magnesium nitrate, hexahydrate, 99+%, ACSfrom Glentham Life Sciences |
GX1786-500 |
500: 88.90 EUR |
Magnesium nitrate hexahydrate, Hi-LR™from EWC Diagnostics |
GRM1052-500G |
1 unit: 6.93 EUR |
Magnesium nitrate hexahydrate, Hi-AR™from EWC Diagnostics |
GRM1380-500G |
1 unit: 9.49 EUR |
Magnesium Nitrate Hexahydrate, 1 M, 100 MLfrom MiTeGen |
M-CSS-214 |
100 ml: 86.00 EUR |
Magnesium nitrate hexahydrate, Hi-AR™/ACfrom EWC Diagnostics |
GRM3923-500G |
1 unit: 9.80 EUR |
Magnesium nitrate hexahydrate ACS Reagent Gradefrom Pfaltz & Bauer |
M00505 |
100G: 243.30 EUR |
GFAAS Matrix Modifer Sol Magnesium Nitrate 2% in 5% HNO3 - 100MLfrom Scientific Laboratory Supplies |
MMS601 |
100ML: 768.18 EUR |
GFAAS Matrix Modifer Sol Magnesium Nitrate 2% in 5% HNO3 - 500MLfrom Scientific Laboratory Supplies |
MMS605 |
500ML: 1148.60 EUR |
Magnesiumfrom Toronto Research Chemicals |
M110320 |
100g: 201.00 EUR |
Magnesium Oxidefrom NACALAI TESQUE |
20921-75 |
500G: 24.50 EUR |
Magnesium Oxidefrom NACALAI TESQUE |
20923-42 |
25G: 12.60 EUR |
The Influence of Synthesis Method on Characteristics of Buffer and Organic Solutions of Thermo- and pH-Responsive Poly( N-[3-(diethylamino)propyl]methacrylamide)s
Detonation nanodiamonds as enhancers of E. coli photodynamic inactivation by phthalocyanines in a high molarity buffer solution
Tunneling in the Hydrogen-Transfer Reaction from a Vitamin E Analog to an Inclusion Complex of 2,2-Diphenyl-1-picrylhydrazyl Radical with β-Cyclodextrin in an Aqueous Buffer Solution at Ambient Temperature
Buffer concentration dramatically affects the stability of S-nitrosothiols in aqueous solutions
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum
Glycine buffer solutionfrom Glentham Life Sciences |
GB7317-1 |
1: 52.80 EUR |
Glycine buffer solutionfrom Glentham Life Sciences |
GB7317-250 |
250: 22.70 EUR |
Ammonium Buffer Solutionfrom EWC Diagnostics |
R061-1L |
1 unit: 80.69 EUR |
pH 9.23 Buffer Solutionfrom Scientific Laboratory Supplies |
10922CTT |
1L: 37.28 EUR |
BUFFER SOLUTION, pH 7.0from PhytoTechnology Laboratories |
B236 |
4000ML: 20.77 EUR |
BUFFER SOLUTION, pH 10.0from PhytoTechnology Laboratories |
B237 |
4000ML: 20.77 EUR |
BUFFER SOLUTION, pH 4.0from PhytoTechnology Laboratories |
B235 |
4000ML: 20.77 EUR |
Buffer solution, pH 9.0from Glentham Life Sciences |
GE4974-1 |
1: 27.80 EUR |
Buffer solution, pH 9.0from Glentham Life Sciences |
GE4974-1L |
1 l: 69.60 EUR |
Buffer solution, pH 7.4from Glentham Life Sciences |
GE5737-1 |
1: 27.80 EUR |
Buffer solution, pH 4.0from Glentham Life Sciences |
GE5959-1 |
1: 27.80 EUR |
Buffer solution, pH 4.0from Glentham Life Sciences |
GE5959-1L |
1 l: 69.60 EUR |
Buffer solution, pH 10.0from Glentham Life Sciences |
GE6195-1 |
1: 29.20 EUR |
Buffer solution, pH 7.0from Glentham Life Sciences |
GE8685-1 |
1: 27.80 EUR |
Buffer solution, pH 7.0from Glentham Life Sciences |
GE8685-1L |
1 l: 69.60 EUR |
Buffer Solution pH3 - 1Lfrom Scientific Laboratory Supplies |
4000600 |
1L: 82.35 EUR |
5x TBE Buffer Solutionfrom Bioatlas |
BA01805 |
6x100ml: 112.80 EUR |
SMP Buffer Solution - 1Lfrom Scientific Laboratory Supplies |
SMPB01 |
1L: 102.60 EUR |
TBE BUFFER SOLUTION (5x)from PhytoTechnology Laboratories |
T773 |
1000ML: 20.04 EUR |
10x TAE Buffer Solutionfrom Bioatlas |
BA01801 |
6x100ml: 116.40 EUR |
10x PBS Buffer Solutionfrom Bioatlas |
BA01802 |
6x100ml: 116.40 EUR |
Biglycan Has a Major Role in Maintenance of Mature Tendon Mechanics
Decorin and biglycan are two small leucine-rich proteoglycans (SLRPs) that regulate collagen fibrillogenesis and extracellular matrix assembly in tendon.
Whole genome sequencing has the potential to improve treatment for rifampicin-resistant tuberculosis in high burden settings: a retrospective cohort study
Determination of volatile phenols in red wines by dispersive liquid-liquid microextraction and gas chromatography-mass spectrometry detection.
High-performance liquid chromatography method development and validation for simultaneous determination of five model compounds, antipyrine, metoprolol, ketoprofen, furosemide and phenol red, as a tool for the standardization of rat in situ intestinal permeability studies using timed wavelength detection.
A simple and rapid high-performance liquid chromatography method for determining furosemide, hydrochlorothiazide, and phenol red: applicability to intestinal permeability studies.
Construction of a colorimetric sensor array based on the coupling reaction to identify phenols
Ultrafast Proton-Transfer Reaction in Phenol-(Ammonia) n Clusters: An Ab Initio Molecular Dynamics Investigation
Inhibition studies of bacterial α-carbonic anhydrases with phenols
HBSS(+) with Ca, Mg and Phenol Red, liquidfrom NACALAI TESQUE |
17459-55 |
500ML: 14.70 EUR |
HBSS(-) without Ca, Mg and Phenol Red, liquidfrom NACALAI TESQUE |
17461-05 |
500ML: 13.30 EUR |
HBSS(+) with Ca, Mg, without Phenol Red, liquidfrom NACALAI TESQUE |
09735-75 |
500ML: 13.65 EUR |
HBSS(-) without Ca and Mg, with Phenol Red, liquidfrom NACALAI TESQUE |
17460-15 |
500ML: 8.75 EUR |
RPMI 1640 with L-Gln, without Phenol Red, liquidfrom NACALAI TESQUE |
06261-65 |
500ML: 9.80 EUR |
DMEM(4.5g/l Glucose) without L-Gln, Sodium Pyruvate and Phenol Red, liquidfrom NACALAI TESQUE |
08489-45 |
500ML: 9.80 EUR |
DMEM(1.0g/l Glucose) with Sodium Pyruvate, without L-Gln and Phenol Red, liquidfrom NACALAI TESQUE |
08490-05 |
500ML: 18.20 EUR |
DMEM/Ham's F-12 with L-Gln, Sodium Pyruvate and HEPES, without Phenol Red, liquidfrom NACALAI TESQUE |
05177-15 |
500ML: 19.60 EUR |
DMEM/Ham's F-12 with L-Gln and Sodium Pyruvate, without HEPES and Phenol Red, liquidfrom NACALAI TESQUE |
11582-05 |
500ML: 42.00 EUR |
Phenol Redfrom NACALAI TESQUE |
26807-21 |
1G: 18.90 EUR |
Phenol Redfrom NACALAI TESQUE |
26807-92 |
25G: 34.30 EUR |
Phenol Redfrom Glycomatrix |
41640000-1 |
25 g: 27.86 EUR |
Phenol Redfrom Glycomatrix |
41640000-2 |
50 g: 44.81 EUR |
Phenol Redfrom Biomatik Corporation |
A3616-25G |
25G: 35.20 EUR |
Phenol Redfrom Biomatik Corporation |
A3616-5G |
5G: 15.40 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-100 |
100: 79.10 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-100G |
100 g: 132.00 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-25 |
25: 31.70 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-250 |
250: 150.40 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-250G |
250 g: 217.20 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-25G |
25 g: 74.40 EUR |
Phenol Redfrom Glentham Life Sciences |
GT9844-5 |
5: 15.90 EUR |
Isolation of exosome from the culture medium of Nasopharyngeal cancer (NPC) C666-1 cells using inertial based Microfluidic channel
Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer
Understanding the Role and Clinical Applications of Exosomes in Gynecologic Malignancies: A Review of the Current Literature
Pathogenic Mechanisms of Preeclampsia with Severe Features Implied by the Plasma Exosomal miRNA Profile
Exosome Isolation kit (for cell culture media) |
|
10 rxn | 199 EUR |
Exosome Isolation kit (for cell culture media) |
|
40 rxn | 769 EUR |
Exosome Isolation kit (for cell culture media) |
|
2 rxn | 69 EUR |
Exosome Isolation kit (for stem cell culture media) |
|
10 rxn | 199 EUR |
Exosome Isolation kit (for stem cell culture media) |
|
2 rxn | 69 EUR |
VEX Exosome Isolation Reagent (from cell culture media) |
|
50 ml | 706.8 EUR |
Reagent for Total Exosome Isolation (Culture Media Supplement) |
|
50 ml | 2485.2 EUR |
T-Pro Total Exosome Isolation reagent (from cell culture media) |
|
500ml/BT | 800 EUR |
T-Pro Total Exosome Isolation reagent (from cell culture media) |
|
100ml/BT | 200 EUR |
ExoQualiTM Overall Exosome Isolation Reagent (from cell culture media) |
|
10 T | Ask for price |
GenMark ePlex NATtrol
In March, GenMark received EUA for its ePlex SARS-CoV-2 Test. Respiratory Pathogen Panel. Multiplex molecular diagnostic solutions provider GenMark Diagnostics has secured CE mark approval for its ePlex respiratory pathogen panel 2 (RP2). The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media. COVID-19. ;
The RP2 Panel provides results in less than two hours for more than 20 viruses and bacteria that cause common respiratory infections with similar symptoms, including COVID-19, flu, bronchitis, and the common cold. Clinical implications of rapid eplex® respiratory pathogen panel testing compared to laboratory-developed real-time PCR Anneloes L. van Rijn, Roel H.T. Due to the batch-wise testing, laboratory-developed real-time polymerase chain reaction (PCR) assays (LDT) often result in a time to result of one day.
10/01/2019: Under Article Text added the third bullet point verbiage “For dates of service on or after 10/1/2019, laboratories billing for services using GenMark” ePlex Respiratory Pathogen (RP) Panel should report 0115U. The ePlex RP2 Control M451 is composed of synthetic DNA and RNA specifically designed for and intended to be used solely with the ePlex RP2 Panel on the ePlex System. In March, GenMark received EUA for its ePlex SARS-CoV-2 Test. Read More.
The ePlex respiratory pathogen panel (RP panel) is a novel molecular biology-based assay, developed by GenMark Diagnostics, Inc. (Carlsbad, CA), to be performed within a single cartridge for the diagnosis of 25 respiratory pathogens (viral and bacterial). in Top News. GenMarkâs ePLex-BCID Gram-Positive panel detects 20 bacterial targets, and the Fungal Pathogen panel detects 13 yeast pathogens in one and a half hours. AB Molecular Ltd. Butyl Road, Botolph Claydon, Respiratory Pathogen Panel. AB Molecular is the exclusive distributor in the UK for GenMark Dx and has been established to promote their innovative ePlex technology.
The ePlex RP2 Panel is designed for use with the companyâs ePlex system, which has been cleared by the FDA for use with the ePlex Respiratory Pathogen (RP) Panel and Blood Culture Identification (BCID) Panels (Gram-positive, Gram-negative and Fungal pathogens). The QIAstat-Dx® RP assay detected 312 of the 338 respiratory targets (92%) that were detected by the ePlex® RPP assay. This assay does NOT detect SARS CoV-2 (novel coronavirus) or MERS. Multiplex molecular panels provide high sensitivity (few false negatives) and specificity (few false positives) for multiple pathogens in ⦠GenMarkâs ePlex Respiratory Pathogen Panel 2 (RP2) achieves CE mark.
The company said RP2 drove the majority of the placements and revenues in Q3. Respiratory Panel 2 (RP2)] 0115U Respiratory infectious agent detection by nucleic acid (DNA and RNA), 18 viral types and subtypes and 2 bacterial targets, amplified probe technique, including multiplex reverse transcription for RNA targets, each analyte reported as detected or not detected [USE FOR GenMark ePlex Respiratory Pathogen (RP) Panel] SARS-CoV-2 (2 assays) Seasonal coronavirus.
We are very pleased to announce the 510(k) clearance of ePlex and the Respiratory Pathogen Panel. The new RP2 panel includes SARS-CoV-2, the pathogen that causes COVID-19. If the tube system is used, ensure specimens are in leak-proof containers that are securely closed and double bagged. ORIGINAL ARTICLE Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR Anneloes L. van Rijn1 & Roel H. T. Nijhuis1 & Vincent Bekker 2 & Geert H.
Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.
This report has been ready by the European Academy of Allergy and Clinical Immunology Task Force on Allergic Rhinitis (AR) comorbidities. The goal of this multidisciplinary European consensus doc is to spotlight the function of multimorbidities in the definition, classification, mechanisms, suggestions for prognosis and remedy of AR, and to outline the wants in this uncared for space by a literature overview.
AR is a systemic allergic illness and is mostly related to quite a few multi-morbid problems, together with bronchial asthma, eczema, meals allergic reactions, eosinophilic oesophagitis (EoE), conjunctivitis, power center ear effusions, rhinosinusitis, adenoid hypertrophy, olfaction problems, obstructive sleep apnea, disordered sleep and consequent behavioural and instructional results.
This report supplies up-to-date usable data to: (1) enhance the data and expertise of allergists, in order to in the end enhance the general high quality of affected person care; (2) to extend curiosity in this space; and (3) to current a singular contribution to the sphere of higher inflammatory illness.
A piece group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles ought to obtain particular consideration for doable hostile well being outcomes in human topics.
Ultrafine particles (UFPs) are airborne particulates of lower than 100 nm in aerodynamic diameter. Examples of UFPs are diesel exhaust particles, merchandise of cooking, heating, and wooden burning in indoor environments, and, extra not too long ago, merchandise generated by the use of nanotechnology. Studies have proven that ambient UFPs have detrimental results on each the cardiovascular and respiratory techniques, together with the next incidence of atherosclerosis and exacerbation fee of bronchial asthma.
HighQC™ Human Cord Blood-CD34+ Hematopoietic Stem Cell |
|||
ABC-SC0085T | AcceGen | 1 vial | Ask for price |
Description: Desired cells are isolated using positive magnetic isolation of CD34 from cord blood. CD34+ cells are targeted using uniform, superparamagnetic polymer beads coated with a primary monoclonal antibody specific for the CD34 membrane antigen predominantly expressed on human hematopoietic progenitor cells and endothelial progenitor cells. The isolated cells are poured off into a new tube, and are cryogenically preserved. |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), 0.2mg/mL |
|||
BNUB1807-100 | Biotium | 1uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), 0.2mg/mL |
|||
BNUB1807-500 | Biotium | 1uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), 1mg/mL |
|||
BNUM1807-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Human Uncharacterized hematopoietic stem/progenitor cells protein MDS032 / MDS032 (USE1) ELISA Kit |
|||
abx384157-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human Uncharacterized hematopoietic stem/progenitor cells protein MDS032 / MDS032 (USE1) ELISA Kit |
|||
abx384157-1096tests | Abbexa | 10 × 96 tests | Ask for price |
Human Uncharacterized hematopoietic stem/progenitor cells protein MDS032 / MDS032 (USE1) ELISA Kit |
|||
abx384157-596tests | Abbexa | 5 × 96 tests | Ask for price |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), 0.2mg/mL |
|||
BNUB2184-100 | Biotium | 1uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), 0.2mg/mL |
|||
BNUB2184-500 | Biotium | 1uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 0.2mg/mL |
|||
BNUB2185-100 | Biotium | 100uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 0.2mg/mL |
|||
BNUB2185-500 | Biotium | 500uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 0.2mg/mL |
|||
BNUB2598-100 | Biotium | 100uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 0.2mg/mL |
|||
BNUB2598-500 | Biotium | 500uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), 1mg/mL |
|||
BNUM2184-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 1mg/mL |
|||
BNUM2185-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 1mg/mL |
|||
BNUM2598-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNUB2185-50 | Biotium | 50uL | EUR 486 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNUB2598-50 | Biotium | 50uL | EUR 486 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC702185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF770 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC702185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF770 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC702598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF770 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC702598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF770 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC802185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC802185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC802598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC802598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC812185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680R conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC812185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC812598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC812598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680R conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC552185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF555 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC552185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF555 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC552598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF555 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC552598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF555 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC432598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF543 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC432598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF543 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC612185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF660R conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC612185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF660R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC612598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF660R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC612598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF660R conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC432185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF543 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC432185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF543 conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC052185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405M conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNC052185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405M conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC052598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405M conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNC052598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405M conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCA2185-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), APC conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCA2598-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), APC conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCAP2185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCAP2185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCAP2598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCAP2598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCH2185-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCH2185-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCH2598-100 | Biotium | 100uL | EUR 279.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCH2598-500 | Biotium | 500uL | EUR 654 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCP2185-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), PerCP conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCP2598-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), PerCP conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody |
|||
BNCR2185-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), RPE conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody |
|||
BNCR2598-250 | Biotium | 250uL | EUR 472.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), RPE conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R), 0.2mg/mL |
|||
BNUB1806-100 | Biotium | 100uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R), 0.2mg/mL |
|||
BNUB1806-500 | Biotium | 500uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R), 1mg/mL |
|||
BNUM1806-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC701806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF770 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC701806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF770 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC801806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC801806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC811806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC811806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC551806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF555 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC551806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF555 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC611806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF660R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC611806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF660R conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC431806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF543 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC431806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF543 conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC051806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF405M conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNC051806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF405M conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCA1806-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),APC conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCAP1806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCAP1806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCH1806-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCH1806-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCP1806-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),PerCP conjugate, Concentration: 0.1mg/mL |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody |
|||
BNCR1806-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),RPE conjugate, Concentration: 0.1mg/mL |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker); Clone 3D3 (Concentrate) |
|||
RA0264-C.1 | ScyTek Laboratories | 0.1 ml | EUR 60.07 |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker); Clone 3D3 (Concentrate) |
|||
RA0264-C.5 | ScyTek Laboratories | 0.5 ml | EUR 200.66 |
anti-CD34 Hematopoietic precursor cells |
|||
513-A | Virogen | 1 MG | EUR 850 |
anti-CD34 Hematopoietic precursor cells |
|||
513-A-01mg | Virogen | 0,1 mg | EUR 321 |
Description: anti-CD34 Hematopoietic precursor cells |
anti-CD34 Hematopoietic precursor cells |
|||
513-A-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: anti-CD34 Hematopoietic precursor cells |
anti-CD34 Hematopoietic precursor cells |
|||
513-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: anti-CD34 Hematopoietic precursor cells |
CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Concentrate) |
|||
RA0052-C.1 | ScyTek Laboratories | 0.1 ml | EUR 60.07 |
CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Concentrate) |
|||
RA0052-C.5 | ScyTek Laboratories | 0.5 ml | EUR 200.66 |
CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Concentrate) |
|||
RA0053-C.1 | ScyTek Laboratories | 0.1 ml | EUR 60.07 |
CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Concentrate) |
|||
RA0053-C.5 | ScyTek Laboratories | 0.5 ml | EUR 200.66 |
Anti-Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Monoclonal Antibody |
|||
M03359 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Mouse Monoclonal Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody. Validated in Flow Cytometry, IP and tested in Human, Rabbit, Rat. |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF568 conjugate, 0.1mg/mL |
|||
BNC681807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF568 conjugate, 0.1mg/mL |
|||
BNC681807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF647 conjugate, 0.1mg/mL |
|||
BNC471807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF647 conjugate, 0.1mg/mL |
|||
BNC471807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF594 conjugate, 0.1mg/mL |
|||
BNC941807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF594 conjugate, 0.1mg/mL |
|||
BNC941807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Monoclonal Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody, Clone: 3D3 |
|||
AMM01202G | Leading Biology | 7 ml | EUR 580.8 |
Description: A Monoclonal antibody against Human Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker). The antibodies are raised in Mouse and are from clone 3D3. This antibody is applicable in WB, IHC and IF, FC, IP |
Monoclonal Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody, Clone: 2A4 |
|||
AMM01205G | Leading Biology | 7 ml | EUR 580.8 |
Description: A Monoclonal antibody against Human Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker). The antibodies are raised in Mouse and are from clone 2A4. This antibody is applicable in IHC, IF, FC |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF488A conjugate, 0.1mg/mL |
|||
BNC881807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF488A conjugate, 0.1mg/mL |
|||
BNC881807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF405S conjugate, 0.1mg/mL |
|||
BNC041807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF405S conjugate, 0.1mg/mL |
|||
BNC041807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF640R conjugate, 0.1mg/mL |
|||
BNC401807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF640R conjugate, 0.1mg/mL |
|||
BNC401807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), Biotin conjugate, 0.1mg/mL |
|||
BNCB1807-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), Biotin conjugate, 0.1mg/mL |
|||
BNCB1807-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Monoclonal CD34 (Hematopoietic Stem Cell & Endothelial Marker) Antibody, Clone: SPM123 |
|||
AMM01547G | Leading Biology | 7 ml | EUR 580.8 |
Description: A Monoclonal antibody against Human CD34 (Hematopoietic Stem Cell & Endothelial Marker). The antibodies are raised in Mouse and are from clone SPM123. This antibody is applicable in IHC, IF, FC |
Monoclonal CD34 (Hematopoietic Stem Cell & Endothelial Marker) Antibody, Clone: SPM610 |
|||
AMM01557G | Leading Biology | 7 ml | EUR 580.8 |
Description: A Monoclonal antibody against Human CD34 (Hematopoietic Stem Cell & Endothelial Marker). The antibodies are raised in Mouse and are from clone SPM610. This antibody is applicable in WB, IHC and IF, FC |
Rat Bone Marrow PrimaCell: Hematopoietic Cells |
|||
2-82590 | CHI Scientific | 1 Kit | Ask for price |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF594 conjugate, 0.1mg/mL |
|||
BNC942598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF594 conjugate, 0.1mg/mL |
|||
BNC942598-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF568 conjugate, 0.1mg/mL |
|||
BNC682184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF568 conjugate, 0.1mg/mL |
|||
BNC682184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF568 conjugate, 0.1mg/mL |
|||
BNC682185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF568 conjugate, 0.1mg/mL |
|||
BNC682185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF568 conjugate, 0.1mg/mL |
|||
BNC682598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF568 conjugate, 0.1mg/mL |
|||
BNC682598-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF647 conjugate, 0.1mg/mL |
|||
BNC472184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF647 conjugate, 0.1mg/mL |
|||
BNC472184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF647 conjugate, 0.1mg/mL |
|||
BNC472185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF647 conjugate, 0.1mg/mL |
|||
BNC472185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF647 conjugate, 0.1mg/mL |
|||
BNC472598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF647 conjugate, 0.1mg/mL |
|||
BNC472598-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF594 conjugate, 0.1mg/mL |
|||
BNC942184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF594 conjugate, 0.1mg/mL |
|||
BNC942184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF594 conjugate, 0.1mg/mL |
|||
BNC942185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF594 conjugate, 0.1mg/mL |
|||
BNC942185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF488A conjugate, 0.1mg/mL |
|||
BNC882184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF488A conjugate, 0.1mg/mL |
|||
BNC882184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF488A conjugate, 0.1mg/mL |
|||
BNC882185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF488A conjugate, 0.1mg/mL |
|||
BNC882185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF488A conjugate, 0.1mg/mL |
|||
BNC882598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF488A conjugate, 0.1mg/mL |
|||
BNC882598-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF640R conjugate, 0.1mg/mL |
|||
BNC402598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF640R conjugate, 0.1mg/mL |
|||
BNC402598-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF405S conjugate, 0.1mg/mL |
|||
BNC042184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF405S conjugate, 0.1mg/mL |
|||
BNC042184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405S conjugate, 0.1mg/mL |
|||
BNC042185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405S conjugate, 0.1mg/mL |
|||
BNC042185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405S conjugate, 0.1mg/mL |
|||
BNC042598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405S conjugate, 0.1mg/mL |
|||
BNC042598-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF640R conjugate, 0.1mg/mL |
|||
BNC402184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF640R conjugate, 0.1mg/mL |
|||
BNC402184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF640R conjugate, 0.1mg/mL |
|||
BNC402185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF640R conjugate, 0.1mg/mL |
|||
BNC402185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), Biotin conjugate, 0.1mg/mL |
|||
BNCB2184-100 | Biotium | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), Biotin conjugate, 0.1mg/mL |
|||
BNCB2184-500 | Biotium | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Biotin conjugate, 0.1mg/mL |
|||
BNCB2185-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Biotin conjugate, 0.1mg/mL |
|||
BNCB2185-500 | Biotium | 500uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Biotin conjugate, 0.1mg/mL |
|||
BNCB2598-100 | Biotium | 100uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
UFPs have been discovered to change in vitro and in vivo responses of the immune system to allergens and may also play a task in allergen sensitization. The inflammatory properties of UFPs may be mediated by a quantity of totally different mechanisms, together with the power to provide reactive oxygen species, resulting in the era of proinflammatory cytokines and airway irritation.
In addition, as a result of of their small measurement, UFPs even have distinctive distribution traits in the respiratory tree and circulation and would possibly be capable of alter mobile perform in ways in which circumvent regular signaling pathways.
Additionally, UFPs can penetrate intracellularly and probably trigger DNA injury. The current advances in nanotechnology, though opening up new alternatives for the development of expertise and medication, may additionally result in unexpected hostile well being results in uncovered human topics.
Further analysis is required to make clear the protection of nanoscale particles, in addition to the elucidation of the doable helpful use of these particulates to deal with illness.
AllergoOncology: Microbiota in allergy and cancer-A European Academy for Allergy and Clinical Immunology position paper.
Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology.
This EAACI position paper goals at offering a state-of-the-art overview on nonallergic rhinitis (NAR). A big variety of sufferers affected by persistent rhinitis are outlined as nonallergic noninfectious rhinitis (NANIR) sufferers, usually denominated in quick as having NAR.
NAR is outlined as a symptomatic irritation of the nasal mucosa with the presence of a minimal of two nasal signs comparable to nasal obstruction, rhinorrhea, sneezing, and/or itchy nostril, with out medical proof of endonasal an infection and with out systemic indicators of sensitization to inhalant allergens. Symptoms of NAR might have a variety of severity and be both constantly current and/or induced by publicity to unspecific triggers, additionally known as nasal hyperresponsiveness (NHR).
FBXW5 |
|||
CSB-CL846577HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
FBXW5 siRNA |
|||
20-abx916666 | Abbexa |
|
|
FBXW5 siRNA |
|||
20-abx916667 | Abbexa |
|
|
FBXW5 siRNA |
|||
20-abx901921 | Abbexa |
|
|
FBXW5 Antibody |
|||
1-CSB-PA846577LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against FBXW5. Recognizes FBXW5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
FBXW5 Antibody |
|||
DF13011 | Affbiotech | 200ul | EUR 420 |
FBXW5 Antibody |
|||
DF13011-100ul | Affinity Biosciences | 100ul | EUR 280 |
FBXW5 Antibody |
|||
DF13011-200ul | Affinity Biosciences | 200ul | EUR 350 |
FBXW5 Antibody |
|||
E312026 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
FBXW5 Antibody |
|||
CAC07669-100ug | Biomatik Corporation | 100ug | EUR 314 |
FBXW5 Antibody |
|||
CAC07669-50ug | Biomatik Corporation | 50ug | EUR 199.2 |
FBXW5 Rabbit pAb |
|||
A9345-100ul | Abclonal | 100 ul | EUR 369.6 |
FBXW5 Rabbit pAb |
|||
A9345-200ul | Abclonal | 200 ul | EUR 550.8 |
FBXW5 Rabbit pAb |
|||
A9345-20ul | Abclonal | 20 ul | EUR 219.6 |
FBXW5 Rabbit pAb |
|||
A9345-50ul | Abclonal | 50 ul | EUR 267.6 |
FBXW5 Rabbit pAb |
|||
E2509345 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
FBXW5 rabbit pAb |
|||
E28PN3174 | EnoGene | 100μl | EUR 255 |
Description: Available in various conjugation types. |
FBXW5 rabbit pAb |
|||
E44H12058 | EnoGene | 100ul | EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
anti- FBXW5 antibody |
|||
FNab03056 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against FBXW5 |
FBXW5 cloning plasmid |
|||
CSB-CL846577HU1-10ug | Cusabio | 10ug | EUR 703.2 |
Description: A cloning plasmid for the FBXW5 gene. |
FBXW5 cloning plasmid |
|||
CSB-CL846577HU2-10ug | Cusabio | 10ug | EUR 292.8 |
Description: A cloning plasmid for the FBXW5 gene. |
FBXW5 Blocking Peptide |
|||
DF13011-BP | Affbiotech | 1mg | EUR 234 |
FBXW5 Polyclonal Antibody |
|||
31706 | SAB | 100ul | EUR 439 |
FBXW5 Polyclonal Antibody |
|||
31706-100ul | SAB | 100ul | EUR 302.4 |
FBXW5 Polyclonal Antibody |
|||
31706-50ul | SAB | 50ul | EUR 224.4 |
FBXW5 Polyclonal Antibody |
|||
E916694 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
FBXW5 Polyclonal Antibody |
|||
E99345 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
FBXW5 Polyclonal Antibody |
|||
E-AB-68018-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
FBXW5 Polyclonal Antibody |
|||
E-AB-68018-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
FBXW5 Polyclonal Antibody |
|||
E-AB-68018-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
FBXW5 Polyclonal Antibody |
|||
E-AB-68018-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
FBXW5 ELISA KIT|Human |
|||
EF009597 | Lifescience Market | 96 Tests | EUR 826.8 |
Rat FBXW5 shRNA Plasmid |
|||
20-abx990317 | Abbexa |
|
|
Mouse FBXW5 shRNA Plasmid |
|||
20-abx974031 | Abbexa |
|
|
Human FBXW5 shRNA Plasmid |
|||
20-abx960068 | Abbexa |
|
|
FBXW5 (untagged)-Human F-box and WD repeat domain containing 5 (FBXW5) |
|||
SC111816 | Origene Technologies GmbH | 10 µg | Ask for price |
FBXW5 Antibody, HRP conjugated |
|||
1-CSB-PA846577LB01HU | Cusabio |
|
|
Description: A polyclonal antibody against FBXW5. Recognizes FBXW5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
FBXW5 Recombinant Protein (Rat) |
|||
RP201080 | ABM | 100 ug | Ask for price |
FBXW5 Antibody, FITC conjugated |
|||
1-CSB-PA846577LC01HU | Cusabio |
|
|
Description: A polyclonal antibody against FBXW5. Recognizes FBXW5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
OACA09653-50UG - FBXW5 Antibody |
|||
OACA09653-50UG | Aviva Systems Biology | 50ug | EUR 179 |
FBXW5 Recombinant Protein (Human) |
|||
RP011965 | ABM | 100 ug | Ask for price |
FBXW5 Recombinant Protein (Human) |
|||
RP011968 | ABM | 100 ug | Ask for price |
FBXW5 Recombinant Protein (Mouse) |
|||
RP134156 | ABM | 100 ug | Ask for price |
FBXW5 Antibody, Biotin conjugated |
|||
1-CSB-PA846577LD01HU | Cusabio |
|
|
Description: A polyclonal antibody against FBXW5. Recognizes FBXW5 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
OACA09653-100UG - FBXW5 Antibody |
|||
OACA09653-100UG | Aviva Systems Biology | 100ug | EUR 319 |
Fbxw5 (GFP-tagged) - Mouse F-box and WD-40 domain protein 5 (Fbxw5) |
|||
MG209019 | Origene Technologies GmbH | 10 µg | Ask for price |
FBXW5 (GFP-tagged) - Human F-box and WD repeat domain containing 5 (FBXW5) |
|||
RG204371 | Origene Technologies GmbH | 10 µg | Ask for price |
FBXW5 Polyclonal Conjugated Antibody |
|||
C31706 | SAB | 100ul | EUR 476.4 |
Fbxw5 ORF Vector (Rat) (pORF) |
|||
ORF067028 | ABM | 1.0 ug DNA | EUR 607.2 |
Fbxw5 ORF Vector (Mouse) (pORF) |
|||
ORF044720 | ABM | 1.0 ug DNA | EUR 607.2 |
FBXW5 ORF Vector (Human) (pORF) |
|||
ORF003989 | ABM | 1.0 ug DNA | EUR 114 |
FBXW5 ORF Vector (Human) (pORF) |
|||
ORF003990 | ABM | 1.0 ug DNA | EUR 114 |
Fbxw5 (Myc-DDK-tagged) - Mouse F-box and WD-40 domain protein 5 (Fbxw5) |
|||
MR209019 | Origene Technologies GmbH | 10 µg | Ask for price |
Human FBXW5 knockout cell line |
|||
ABC-KH5436 | AcceGen | 1 vial | Ask for price |
Description: Human FBXW5 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
FBXW5 (Myc-DDK-tagged)-Human F-box and WD repeat domain containing 5 (FBXW5) |
|||
RC204371 | Origene Technologies GmbH | 10 µg | Ask for price |
Human FBXW5 knockdown cell line |
|||
ABC-KD5436 | AcceGen | 1 vial | Ask for price |
Description: Human FBXW5 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Fbxw5 (untagged ORF) - Rat F-box and WD repeat domain containing 5 (Fbxw5), (10 ug) |
|||
RN209469 | Origene Technologies GmbH | 10 µg | Ask for price |
Fbxw5 (Myc-DDK-tagged ORF) - Rat F-box and WD repeat domain containing 5 (Fbxw5), (10 ug) |
|||
RR209469 | Origene Technologies GmbH | 10 µg | Ask for price |
Fbxw5 sgRNA CRISPR Lentivector set (Rat) |
|||
K7164801 | ABM | 3 x 1.0 ug | EUR 406.8 |
Lenti ORF clone of Fbxw5 (mGFP-tagged) - Mouse F-box and WD-40 domain protein 5 (Fbxw5) |
|||
MR209019L4 | Origene Technologies GmbH | 10 µg | Ask for price |
FBXW5 sgRNA CRISPR Lentivector set (Human) |
|||
K0767501 | ABM | 3 x 1.0 ug | EUR 406.8 |
Fbxw5 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4573401 | ABM | 3 x 1.0 ug | EUR 406.8 |
FBXW5 3'UTR GFP Stable Cell Line |
|||
TU057812 | ABM | 1.0 ml | EUR 1672.8 |
Fbxw5 3'UTR GFP Stable Cell Line |
|||
TU254532 | ABM | 1.0 ml | Ask for price |
Fbxw5 3'UTR GFP Stable Cell Line |
|||
TU156465 | ABM | 1.0 ml | Ask for price |
Lenti ORF clone of Fbxw5 (Myc-DDK-tagged) - Mouse F-box and WD-40 domain protein 5 (Fbxw5) |
|||
MR209019L3 | Origene Technologies GmbH | 10 µg | Ask for price |
OAGA06424-100UL - FBXW5 Antibody - middle region |
|||
OAGA06424-100UL | Aviva Systems Biology | 100ul | EUR 369 |
OAAB15056-400UL - FBXW5 Antibody - middle region |
|||
OAAB15056-400UL | Aviva Systems Biology | 400ul | EUR 389 |
FBXW5 Protein Vector (Rat) (pPM-C-HA) |
|||
PV268112 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Rat) (pPB-C-His) |
|||
PV268110 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Rat) (pPB-N-His) |
|||
PV268111 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Rat) (pPM-C-His) |
|||
PV268113 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Human) (pPM-C-HA) |
|||
PV015955 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Human) (pPM-C-HA) |
|||
PV015959 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV178880 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Human) (pPB-C-His) |
|||
PV015953 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Human) (pPB-N-His) |
|||
PV015954 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Human) (pPM-C-His) |
|||
PV015956 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Human) (pPB-C-His) |
|||
PV015957 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Human) (pPB-N-His) |
|||
PV015958 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Human) (pPM-C-His) |
|||
PV015960 | ABM | 500 ng | EUR 394.8 |
FBXW5 Protein Vector (Mouse) (pPB-C-His) |
|||
PV178878 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Mouse) (pPB-N-His) |
|||
PV178879 | ABM | 500 ng | EUR 723.6 |
FBXW5 Protein Vector (Mouse) (pPM-C-His) |
|||
PV178881 | ABM | 500 ng | EUR 723.6 |
Fbxw5 3'UTR Luciferase Stable Cell Line |
|||
TU204532 | ABM | 1.0 ml | Ask for price |
FBXW5 3'UTR Luciferase Stable Cell Line |
|||
TU007812 | ABM | 1.0 ml | EUR 1672.8 |
Fbxw5 3'UTR Luciferase Stable Cell Line |
|||
TU106465 | ABM | 1.0 ml | Ask for price |
Fbxw5 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7164802 | ABM | 1.0 ug DNA | EUR 184.8 |
Fbxw5 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7164803 | ABM | 1.0 ug DNA | EUR 184.8 |
Fbxw5 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7164804 | ABM | 1.0 ug DNA | EUR 184.8 |
Lenti ORF particles, Fbxw5 (GFP-tagged) - Mouse F-box and WD-40 domain protein 5 (Fbxw5), 200ul, >10^7 TU/mL |
|||
MR209019L4V | Origene Technologies GmbH | 200 µl | Ask for price |
FBXW5 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K0767502 | ABM | 1.0 ug DNA | EUR 184.8 |
FBXW5 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K0767503 | ABM | 1.0 ug DNA | EUR 184.8 |
FBXW5 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K0767504 | ABM | 1.0 ug DNA | EUR 184.8 |
Fbxw5 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4573402 | ABM | 1.0 ug DNA | EUR 184.8 |
Fbxw5 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4573403 | ABM | 1.0 ug DNA | EUR 184.8 |
Fbxw5 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4573404 | ABM | 1.0 ug DNA | EUR 184.8 |
Lenti ORF clone of Fbxw5 (mGFP-tagged ORF) - Rat F-box and WD repeat domain containing 5 (Fbxw5), (10 ug) |
|||
RR209469L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, FBXW5 (mGFP-tagged) - Human F-box and WD repeat domain containing 5 (FBXW5), 200ul, >10^7 TU/mL |
|||
RC204371L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FBXW5 (mGFP-tagged) - Human F-box and WD repeat domain containing 5 (FBXW5), 200ul, >10^7 TU/mL |
|||
RC204371L4V | Origene Technologies GmbH | 200 µl | Ask for price |
AAP73235-100UG - FBXW5 Peptide - N-terminal region |
|||
AAP73235-100UG | Aviva Systems Biology | 100ug | EUR 99 |
Lenti ORF particles, Fbxw5 (Myc-DDK-tagged) - Mouse F-box and WD-40 domain protein 5 (Fbxw5), 200ul, >10^7 TU/mL |
|||
MR209019L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Fbxw5 (GFP-tagged ORF) - Rat F-box and WD repeat domain containing 5 (Fbxw5), 200ul, >10^7 TU/mL |
|||
RR209469L4V | Origene Technologies GmbH | 200 µl | Ask for price |
ARP73235_P050-25UL - FBXW5 Antibody - N-terminal region |
|||
ARP73235_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
Lenti ORF particles, FBXW5 (Myc-DDK tagged) - Human F-box and WD repeat domain containing 5 (FBXW5), 200ul, >10^7 TU/mL |
|||
RC204371L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, FBXW5 (Myc-DDK tagged) - Human F-box and WD repeat domain containing 5 (FBXW5), 200ul, >10^7 TU/mL |
|||
RC204371L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF clone of Fbxw5 (Myc-DDK-tagged ORF) - Rat F-box and WD repeat domain containing 5 (Fbxw5), (10 ug) |
|||
RR209469L3 | Origene Technologies GmbH | 10 µg | Ask for price |
ARP73235_P050 - FBXW5 Antibody - N-terminal region (ARP73235_P050) |
|||
ARP73235_P050 | Aviva Systems Biology | 100ul | EUR 389 |
Lenti ORF particles, Fbxw5 (Myc-DDK-tagged ORF) - Rat F-box and WD repeat domain containing 5 (Fbxw5), 200ul, >10^7 TU/mL |
|||
RR209469L3V | Origene Technologies GmbH | 200 µl | Ask for price |
FBXW5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV660133 | ABM | 1.0 ug DNA | EUR 818.4 |
FBXW5 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV660137 | ABM | 1.0 ug DNA | EUR 818.4 |
FBXW5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
LV710091 | ABM | 1.0 ug DNA | EUR 379.2 |
FBXW5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
LV710095 | ABM | 1.0 ug DNA | EUR 379.2 |
FBXW5 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV660138 | ABM | 1.0 ug DNA | EUR 818.4 |
FBXW5 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
LV710096 | ABM | 1.0 ug DNA | EUR 379.2 |
Fbxw5 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
SR509182 | Origene Technologies GmbH | 2 nmol | Ask for price |
Fbxw5 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
SR417585 | Origene Technologies GmbH | 2 nmol | Ask for price |
FBXW5 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
SR310085 | Origene Technologies GmbH | 2 nmol | Ask for price |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
20-abx123928 | Abbexa |
|
|
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx031051-400ul | Abbexa | 400 ul | EUR 627.6 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx031051-80l | Abbexa | 80 µl | EUR 343.2 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx233056-100ug | Abbexa | 100 ug | EUR 577.2 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
20-abx313725 | Abbexa |
|
|
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx123928-100l | Abbexa | 100 µl | EUR 175 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx123928-1ml | Abbexa | 1 ml | EUR 400 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx123928-200l | Abbexa | 200 µl | EUR 275 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx031051-400l | Abbexa | 400 µl | EUR 518.75 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx233056-100g | Abbexa | 100 µg | EUR 350 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx313725-100g | Abbexa | 100 µg | EUR 362.5 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx313725-20g | Abbexa | 20 µg | EUR 162.5 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody |
|||
abx313725-50g | Abbexa | 50 µg | EUR 250 |
Fbxw5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7164805 | ABM | 3 x 1.0 ug | EUR 451.2 |
FBXW5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K0767505 | ABM | 3 x 1.0 ug | EUR 451.2 |
Fbxw5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K4573405 | ABM | 3 x 1.0 ug | EUR 451.2 |
Rat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E02F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rat F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E02F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rat F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E02F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rat F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E07F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Porcine F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E07F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Porcine F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E07F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Porcine F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E08F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Canine F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E08F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Canine F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E08F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Canine F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A13321 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Goat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A48230 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Goat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E06F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Goat F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E06F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Goat F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E06F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Goat F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A4557 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Mouse F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A22061 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Mouse F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E03F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Mouse F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E03F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Mouse F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E03F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Mouse F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse F- box/WD repeat- containing protein 5, Fbxw5 ELISA KIT |
|||
ELI-47411m | Lifescience Market | 96 Tests | EUR 1038 |
Human F- box/WD repeat- containing protein 5, FBXW5 ELISA KIT |
|||
ELI-12883h | Lifescience Market | 96 Tests | EUR 988.8 |
Sheep F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A100523 | BlueGene | 96T | EUR 700 |
Description: ELISA |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody (HRP) |
|||
20-abx313726 | Abbexa |
|
|
Canine F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A65661 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Rabbit F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A30798 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Bovine F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A83094 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Rabbit F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E04F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Rabbit F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E04F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Rabbit F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E04F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Rabbit F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E01A74377 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Monkey F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E09F0337-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Monkey F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E09F0337-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Monkey F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey F box/WD repeat containing protein 5(FBXW5) ELISA kit |
|||
E09F0337-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Monkey F box/WD repeat containing protein 5(FBXW5) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody (HRP) |
|||
abx313726-100g | Abbexa | 100 µg | EUR 362.5 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody (HRP) |
|||
abx313726-20g | Abbexa | 20 µg | EUR 162.5 |
F-Box And WD Repeat Domain Containing 5 (FBXW5) Antibody (HRP) |
|||
abx313726-50g | Abbexa | 50 µg | EUR 250 |
NHR represents a medical characteristic of each AR and NAR sufferers. NAR includes totally different subgroups: drug-induced rhinitis, (nonallergic) occupational rhinitis, hormonal rhinitis (together with being pregnant rhinitis), gustatory rhinitis, senile rhinitis, and idiopathic rhinitis (IR).
NAR must be distinguished from these rhinitis sufferers with an allergic response confined to the nasal mucosa, additionally known as “entopy” or native allergic rhinitis (LAR). We right here present an outline of the present consensus on phenotypes of NAR, suggestions for analysis, a remedy algorithm, and defining the unmet wants in this uncared for space of analysis.